<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/259306-skin-lightening-agents-compositions-and-methods by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 02:29:55 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 259306:SKIN LIGHTENING AGENTS, COMPOSITIONS AND METHODS</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">SKIN LIGHTENING AGENTS, COMPOSITIONS AND METHODS</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>Cosmetic compositions and methods are provided, particularly for skin lightening, using 7-hydroxy-2-phenyl coumarin and derivatives of general formula (I) as skin lightening agents alone or in combination with other skin benefit agents and together with a cosmetic vehicle: (I) wherein R1 and/or R2 may be positioned at the 1-, 2-, 3-, 5-, and/or 6- positions on the phenyl ring; each or both R1 and/or R2 represents a hydrogen atom, OH, C1-C4 acyl group, or C1-C4 alkyl group; and R represents a hydrogen atom, C1-C4 acyl group, or C1-C4 alkyl group.</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td>FORM - 2<br>
THE PATENTS ACT, 1970<br>
(39 of 1970)<br>
&amp;<br>
The Patents Rules, 2003<br>
COMPLETE SPECIFICATION<br>
(See Section 10 and Rule 13)<br><br><br>
SKIN LIGHTENING AGENTS, COMPOSITIONS AND METHODS<br>
HINDUSTAN UNILEVER LIMITED, a company incorporated under the Indian Companies Act, 1913 and having its registered office at Hindustan Lever House, 165/166, Backbay Reclamation, Mumbai -400 020, Maharashtra, India<br><br>
The following specification particularly describes the invention and the manner in which it is to be performed<br><br><br>
WO 2007/112853	-	PCT/EP2007/002440<br>
SKIN LIGHTENING AGENTS, COMPOSITIONS AND METHODS<br>
The invention relates to cosmetic compositions and methods using 7-hydroxy-3-phenyicoumarin and derivative compounds, and more specifically, using 7-hydroxy-3-phenylcoumarin and derivative compounds as skin lightening agents.<br>
Many people are concerned with the degree of pigmentation of their skin. For example, people with age spots or freckles may wish such pigmented spots to be less pronounced. Others may wish to reduce the skin darkening caused by exposure to sunlight or to lighten their natural skin color. To meet this need, many attempts have been made to develop products that reduce the pigment production in the melanocytes. However, the substances identified thus far tend to have either low efficacy or undesirable side effects, such as, for example, toxicity or skin irritation. Therefore, there is a continuing need for new cosmetic skin lightening agents, with improved overall effectiveness.<br>
For example, certain resorcinol derivatives, particularly 4-substituted resorcinol derivatives, are usefuf in cosmetic compositions for skin tightening benefits, as disclosed in Hu et al., U.S. Patent No. 6,132,740; Bradley, et al., U.S. Patent Nos. 6,504,037 and 6,861,564; Japanese published patent applications JP 2001-010925 and JP2000-327557; and Harichian et al., U.S. Patent No. 6,852,310. Aminophenol derivatives have been described as optical brighteners in, for example, Chevalier et al., U.S. Patent No. 6, 403,065 (for skin).<br>
Applicants have now discovered that 7-hydroxy-3-phenylcoumarin and derivative compounds deliver skin lightening benefits. The general chemical formulas and structures of these compounds are discussed in more detail hereinbelow. The 7-hydroxy-3-phenylcoumarin and derivative compounds have been found to be cosmetically effective and possibly less irritating to the skin. These compounds of the present invention have not been used in cosmetics, nor, specifically, for lightening skin.<br>
The 7-hydroxy-3-phenyicoumarin is available from Sigma-Aldrich as a fluorescent pH probe for the physiological pH range. Raue GB 933042 disloses 3-phenyl-7-hydroxycoumarin compounds as optical brightening agents for textiles.<br><br>
WO 2007/112853<br><br>
PCT/EP2007/002440<br><br>
-2-<br>
SUMMARY OF THE INVENTION<br>
The use of compounds of the general formula I, and compositions including same, delivers skin lightening benefits with potential reduced irritation. The present invention provides a cosmetic composition and method of skin lightening using a composition comprising in 5 addition to a cosmetically acceptable vehicle, about 0.000001 to about 50 % of a compound of general formula I:<br>
(!)<br><br><br><br>
wherein R1 and/or R2 may be positioned at the 1-, 2-, 3-, 5-, and/or 6- positions on the 10      phenyl ring;<br>
each or both R1 and/or R2 represents a hydrogen atom, OH, CrC4 acyl group, or C1-C4<br>
alkyl group; and<br>
R represents a hydrogen atom, C1-C4 acyl group, or C1-C4 alkyl group.<br>
15      Preferably, R represents a hydrogen atom, as represented by compound of general formula II:<br>
(H)<br><br><br><br>
In a more preferred embodiment, R represents a hydrogen atom, and both R1 and R2 represent hydrogen, resulting in the 7-hydroxy-3-phenyicoumarin of formula III (also 20     called 3-phenylumbellifeone):<br>
(III)<br><br><br><br><br>
WO 2007/112853	PCT/EP2007/002440<br>
-3-<br>
Further skin benefit agents may be included in the inventive cosmetic compositions. Organic and inorganic sunscreens may also be included.<br>
The inventive compounds and compositions may be used for reducing overall skin 5     pigmentation and the reduction of discrete hyperpigmentation, such as blemishes and freckles, as well as for reducing the irritation associated with irritating skin benefit agents, such as retinol.<br>
DETAILED DESCRIPTION OF THE INVENTION<br>
10     As used herein, the term "cosmetic composition" is intended to describe compositions for topical application to human skin.<br>
The term "skin" as used herein includes the skin on the face, neck, chest, back, arms, axilla, hands, legs, and scalp.<br>
15<br>
Except in the examples, or where otherwise explicitly indicated, all numbers in this description indicating amounts of material or conditions of reaction, physical properties of materials and/or use are to be understood as modified by the word "about". All amounts are by weight of the composition, unless otherwise specified.<br>
20<br>
It should be noted that in specifying any range of concentration, any particular upper concentration can be associated with any particular lower concentration.<br>
The term "comprising" is used herein in its ordinary meaning and means including, made 25      up of, composed of, consisting and/or consisting essentially of. In other words, the term is defined as not being exhaustive of the steps, components, ingredients, or features to which it refers.<br>
SKIN LIGHTENING AGENTS<br>
30 The invention is concerned with the use of compounds of general formula I, shown below, and compositions including same, as skin cosmetic agents, particularly as skin lightening agents. A particular advantage of the inventive compositions and methods is that compounds of general formula I can be less irritating to the skin than known skin lightening compounds,<br>
35<br><br>
WO 2007/112853<br><br>
PCT/EP2007/002440<br><br>
(I)<br><br>
wherein R, and/or R2 may be positioned at the 1-, 2-, 3-, 5-, and/or 6- positions on the phenyl ring; 5     each or both R1and/or R2 represents a hydrogen atom, C1-C4 acyl group, or C1-C4 alkyl group;and R represents a hydrogen atom, C1-C4 acyl group, or C1-C4 alkyl group.<br>
Preferably R represents a hydrogen atom, as represented by compound of general 10     formula II:<br>
(II)<br><br>
In a more preferred embodiment, R represents a hydrogen atom, and both R1 and R2 15      represent hydrogen, resulting in the 7-hydroxy-3-phenylcoumarin of formula 111 (also called 3-phenylumbelliferone):<br>
(III)<br><br><br>
WO 2007/112853	PCT/EP2007/002440<br>
- 0-<br>
Further skin benefit agents may be included in the inventive cosmetic compositions. Organic and inorganic sunscreens may also be included.<br>
The  inventive  cosmetic  compositions  and  methods  have effective  skin  lightening<br>
5     properties and may be less irritating to the skin.<br>
The compositions generally contain about 0.000001 to about 50 % of compounds of general formula I. Compounds ol formula II and/or III are preferred. The amount of the compound of general formula I or formula II or formula III is preferably in the range of 10 about 0.00001 % to about 10 %, more preferably about 0.001 to about 7 %, most preferably from 0.01 to about 5 %, of the total amount of a cosmetic composition.<br>
OPTIONAL SKIN BENEFIT AGENTS<br>
Preferred cosmetic compositions are those suitable for the application to human skin 15     according to the method of the present invention, which optionally, but preferably, include a further skin benefit agent.<br>
Suitable additional skin benefit agents include anti-aging, wrinkle-reducing, skin whitening, anti-acne, and sebum reduction agents. Examples of these include alpha-20 hydroxy acids, beta-hydroxy acids, polyhydroxy acids, hyaluronic acid, hydroquinone, t-butyl hydroquinone, vitamin B derivatives, vitamin C derivatives, allantoin (a placenta extract), dioic acids, retinoids and resorcinol derivatives.<br>
COSMETICALLY ACCEPTABLE CARRIER 25     The cosmetically acceptable vehicle may act as a dilutant, dispersant or carrier for the skin benefit ingredients in the composition, so as to facilitate their distribution when the composition is applied to the skin.<br>
The vehicle may be aqueous, anhydrous or an emulsion. Preferably, the compositions are 30     aqueous or an emulsion, especially water-in-oil or oil-in-water emulsion, preferentially oil in water emulsion. Water when present wili be in amounts which may range from 5 to 99%, preferably from 20 to 70%, optimally between 40 and 70% by weight.<br>
Besides water, relatively volatile solvents may also serve as carriers within compositions of 35     the present invention. Most preferred are monohydnc C1-C3 alkanols. These include ethyl<br><br>
WO 2007/112853	■	PCT/EP2007/002440<br>
- o-<br>
alcohol, methyl alcohol and isopropyl alcohol. The amount of monohydric alkanol may range from 1 to 70%, preferably from 10 to 50%, optimally between 15 to 40% by weight.<br>
Emollient materials may also serve as cosmetically acceptable carriers. These may be in 5     the form of silicone oils and synthetic esters.   Amounts of the emollients may range anywhere from 0.1 to 50%, preferably between 1 and 20% by weight.<br>
Silicone oils may be divided into the volatile and non-voJatiie variety. The term "volatile" as used herein refers to those materials which have a measurable vapor pressure at ambient temperature. Volatile silicone oils are preferably chosen from cyclic or linear polydimethylsiloxanes containing from 3 to 9, preferably from 4 to 5, silicon atoms. Linear volatile silicone materials generally have viscosities less than about 5 centistokes at 25°C while cyclic materials typically have viscosities of less than about 10 centistokes. Non¬volatile silicone oils useful as an emollient material include polyaikyl siloxanes, polyalkylaryl siloxanes and polyether siloxane copolymers. The essentially non-volatile polyaikyl siloxanes useful herein include, for example, polydimethyl siloxanes with viscosities of from about 5 to about 25 million centistokes at 25°C. Among the preferred non-volatile emollients useful in the present compositions are the polydimethyl siloxanes having viscosities from about 10 to about 400 centistokes at 25°C.<br>
Among the ester emollients are:<br>
(1)	Alkenyl or alkyl esters of fatty acids having 10 to 20 carbon atoms. Examples thereof<br>
include isoarachidyl neopentanoate, isononyl isonanonoate, oleyl myristate, oleyl<br>
25	stearate, and oleyf oleate.<br>
(2)	Ether-esters such as fatty acid esters of ethoxylated fatty alcohols.<br>
(3)	Polyhydric alcohol esters.   Ethylene glycol mono- and di-fatty acid esters, diethylene<br>
30             glycol mono- and di-fatty acid esters, polyethylene glycol (200-6000) mono- and<br>
di-fatty acid esters, propylene glycol mono- and di-fatty acid esters, polypropylene<br>
glycol 2000 monooleate, polypropylene glycol 2000 monostearate, ethoxylated<br>
propylene glycol monostearate, glyceryl mono- and dnfatty acid esters, polyglycerol<br>
poly-fatty esters, ethoxylated glyceryl monostearate, 1,3-butylene glycol monostearate,<br>
35	1,3-butylene glycol distearate, polyoxyethylene polyol fatty acid ester, sorbitan fatty<br><br>
WO 2007/112853	'	PCT/EP2007/002440<br>
- (-<br>
acid esters, and poiyoxyethylene sorbitan fatty acid esters are satisfactory polyhydric alcohol esters.<br>
(4)	Wax esters such as beeswax, spermaceti, myrtstyl myristate, stearyl stearate and<br>
5	arachidyl behenate.<br>
(5)	Sterols esters, of which cholesterol fatty acid esters are examples.<br>
Fatty acids having from 10 to 30 carbon atoms may also be included as cosmetically 10     acceptable carriers for compositions of this invention. IJIustrative of this category are pelargonic,   lauric,   myristic,   palmitic,  stearic,   isostearic,   hydroxystearic,  oleic,   linoleic, ricinoleic, arachidic, behenic and erucic acids.<br>
Humectants of the polyhydric alcohol-type may also be employed as cosmetically acceptable 15 carriers in compositions of this invention. The humectant aids in increasing the effectiveness of the emollient, reduces scaling, stimulates removal of built-up scale and improves skin feel. Typical polyhydric alcohols include glycerol, polyalkylene glycols and more preferably alkylene polyols and their derivatives, including propylene glycol, diprapylene glycol, polypropylene glycol, polyethylene glycol and derivatives thereof, sorbitol, hydroxypropyl 20 sorbitol, hexytene gfycof, 1,3-butylene glycol, 1,2,6-hexanethol, ethoxylated glycerol, propoxylated glycerol and mixtures thereof. For best results the humectant is preferably propylene glycol or sodium hyaluronate. The amount of humectant may range anywhere from 0.5 to 30%, preferably between 1 and 15% by weight of the composition.<br>
25 Thickeners may also be utilized as part of the cosmetically acceptable earner of compositions according to the present invention. Typical thickeners include crosslinked acrylates (e.g. Carbopol 932), hydrophobicatiy-modified acryiates (e.g. Carbopol 1382), cellulosic derivatives and natural gums. Among useful cellulosic derivatives are sodium carboxymeihylcellulose, hydroxypropyl   methylcellulose,   hydroxypropyl   cellulose,   hydroxyethyl   cellulose,   ethyl<br>
30 cellulose and hydroxymethyi cellulose. Natural gums suitable for the present invention include guar, xanthan, sclerotium, carrageenan, pectin and combinations of these gums. Amounts of the thickener may range from 0.0001 to 5%, usually from 0.001 to 1%, optimally from 0.01 to 0.5% by weight.<br><br>
WO 2007/112853	'______		PCT/EP2007/002440<br>
Collectively the water, solvents, silicones, esters, fatty acids, humectants and/or thickeners will constitute the cosmetically acceptable carrier in amounts from 1 to 99.9%, preferably from 80 to 99% by weight.<br>
5 An oil or oily material may be present, together with an emulsifier to provide either a water-in-oil emulsion or an oil-in-water emulsion, depending largely on the average hydrophilic-lipophilic balance (HLB) of the emulsifier employed.<br>
Surfactants may also be present in cosmetic compositions of the present invention.  Total<br>
10     concentration of the surfactant will range from 0.1 to 40%, preferably from 1 to 20%, optimally<br>
from 1 to 5% by weight of the composition. The surfactant may be selected from the group<br>
consisting of anionic, nonionic, cationic and amphoteric actives.  Particularly preferred<br>
nonionic surfactants are those with a C10-C2o fatty alcohol or acid hydrophobe condensed with<br>
from 2 to 100 moles of ethylene oxide or propylene oxide per mole of hydrophobe; C2-Ct0<br>
15     alkyl phenols condensed with from 2 to 20 moles of alkylene oxide; mono- and di- fatty acid<br>
esters of ethylene glycol; fatty acid monoglyceride; sorbitan, mono- and di- C8-C20 fatty acids;<br>
block copolymers (ethylene oxide/propylene oxide); and polyoxyethylene soroitan as well as<br>
combinations thereof.    Alkyl polyglycosides and saccharide fatty amides (e.g.  methyl<br>
gluconamides) are also suitable nonionic surfactants.<br>
20<br>
Preferred anionic surfactants include soap, alkyl ether sulfate and sulfonates, alkyl sulfates and sulfonates, alkylbenzene sulfonates, alkyl and dialkyl sulfosuccinates, C8-C20 acyl isethionates, acyl gfutamates, C8-C2O alkyl ether phosphates and combinations thereof.<br>
25      OPTIONAL COMPONENTS<br>
Other adjunct minor components may also be incorporated into the cosmetic compositions. These ingredients may include coloring agents and/or pigments, opacifiers, perfumes, other thickeners, plasticizers, calamine, antioxidants, chelating agents, as welt as additional sunscreens, such as organic sunscreens.   Amounts of these<br>
30     other adjunct minor components may range anywhere from 0.001% up to 20% by weight of the composition.<br>
For use as sunscreen, metal oxides may be used alone or in mixture and/or in combination with organic sunscreens.   Examples of organic sunscreens include but are 35     not limited those set forth in the table below:<br><br>
WO 2007/112853<br><br>
PCT/EP2007/002440<br><br>
-9-<br>
TABLE 1<br><br>
CTFA Name<br><br>
Trade Name<br><br>
Supplier<br><br><br><br>
5     Benzophenone-1<br>
Benzophenone-2<br>
Benzophenone-3<br>
Benzophenone-4<br>
Benzophenone-8 10      Methoxycinnamate<br>
Ethyl dihydroxypropyl-PABA<br>
Glyceryl PABA<br>
Homosaiate<br>
Methyl anthranilate 15     Octocrylene<br>
Octyl dimethyl PABA<br>
Octyl methoxycinnamate<br>
Octyl salicylate<br>
p-Amino benzoic acid (PABA) 20     2-Phenylbenzimidazole-5-sulphonic<br>
Triethanolamine (TEA) salicylate<br>
3-(4-methylbenzylidene)-camphor<br>
Benzophenone-6<br>
Benzophenone-12 25     4-lsopropyl dibenzoylmethane<br>
Butyl methoxydibenzoylmethane<br>
Etocrylene<br><br>
UVINUL 400 UVINUL D-50 UVINUL M-40 UVINUL MS-40 SPECRA-SORB UV-24 BERNEL HYDRO AMERSCREEN P NIPAG.M.P.A. KEMESTER HMS SUNAROME UVA UVINUL N-539 AMERSCOL PARSOL MCX SUNAROME WMO PABA<br>
acid      EUSOLEX 232 SUNAROME W EUSOLEX 6300 UVINUL D-49 UVINUL 408 EUSOLEX 8020 PARSOL 1789 UVINUL N-35<br><br>
BASF Chemical Co. BASF Chemical Co. BASF Chemical Co. BASF Chemical Co. American Cyanamide Bernel Chemical Amerchol Corp. Nipa Labs. Hunko Chemical Felton Worldwide BASF Chemical Co. Amerchol Corp. Bernel Chemical Felton Worldwide National Starch EM Industries Felton Worldwide EM Industries BASF Chemical Co. BASF Chemical Co. EM Industries Givaudan Corp. BASF  Chemical  Co.<br><br>
30<br>
The amount of the organic sunscreens in the cosmetic composition is preferably in the range of about 0.1 wt % to about 10 wt %, more preferably about 1 wt % to 5 wt %.<br>
Preferred organic sunscreens are Parsol MCX and Parsol 1789, due to their effectiveness 35      and commercial availability.<br>
USE OF THE COMPOSITION<br>
The method according to the invention is intended primarily as using a personal care product for topical application to human skin, for cosmetic benefits induding but not 40     limited to skin lightening.<br><br>
WO 2007/112853		[	_j		PCT/EP2007/002440<br>
-10 *	<br>
The inventive compounds and compositions may be used for reducing overall skin pigmentation and the reduction of discrete hyperpigmentation, such as blemishes and freckles, as well as for reducing the irritation associated with irritating skin benefit agents, such as retinol. 5<br>
In use, a small quantity of the composition, for example from 1 to 5 ml, is applied to areas of the skin, from a suitable container or applicator and, if necessary, it is then spread over and/or rubbed into the skin using the hand or fingers or a suitable device.<br>
10      PRODUCT FORM AND PACKAGING<br>
The cosmetic composition useful for the method of the invention can be formulated as a lotion having a viscosity of from 4,000 to 10,000 mPas, a fluid cream having a viscosity of from 10,000 to 20,000 mPas or a cream having a viscosity of from 20,000 to 100,000 mPas or above. The composition can be packaged in a suitable container to suit its<br>
15 viscosity and intended use by the consumer. For example a lotion or fluid cream can be packaged in a bottle or a roll-ball applicator or a propellant-driven aerosol device or a container fitted with a pump suitable for finger operation. When the composition is a cream, it can simply be stored in a non-deformable bottle or squeeze container, such as a tube or a lidded jar.     When the composition is a solid or semi-solid stick, it may be<br>
20 packaged in a suitable container for manually or mechanically pushing out or extruding the composition.<br>
The invention accordingly also provides a closed container containing a cosmetically acceptable composition as herein defined. 25<br>
The following examples are by way of example, not by way of limitation, of the principles of the present invention, to illustrate the best mode of carrying out the invention.<br>
EXAMPLE 1 30     Cosmetic compositions within the scope of the invention were prepared.   The 7-hydroxy-3-phenylcou ma rin was obtained from Sigrna-Aldrich.<br>
A base formulation shown in the table below was made by heating phase A ingredients to<br>
70 to 85° C with stirring.  Phase B ingredients were heated in a separate container to 70<br>
35     to 85° C with stirring.  Then phase A was added into phase B while both phases were<br><br>
WO 2007/11285*	PCT/EP200 7/002440<br>
- "ll -<br>
kept at 70 to 85° C. The mixture was stirred for at least 15 minutes at 70 to 85° C. then<br>
cooled.<br>
A base formulation is shown in the table below.<br>
TABLE 2<br><br>
2a	2b	<br>
%wt.	%wt.	Phase<br>
6.00	6.00	A<br>
3.00	3.00	A<br>
2.00	2.00	A<br>
1-50	1.50	A<br>
1.50	1.50	A<br>
3.00	4.00	A<br>
1.20	1.20	B<br>
1-00	1.00	A<br>
1.00	1.00	A<br>
0.60	0.60	B<br>
0.10	0.10	A<br>
0.50	0.50	A<br>
0.01	0.01	B<br>
0.20	0.20	B<br>
0.50	0.50	B<br>
0.10	0.10	B<br>
0.05	0.05	B<br>
0.05	0.05	B<br>
0.05	2.00	B<br>
1.00	1.00	B<br>
2.50	5.00	B<br>
0.15	0.15	B<br>
BAL"<br>
100.00	BAL"<br>
100.00<br>
	B<br>
Ingredients<br>
Isostearyl palmitate<br>
C12-C15 alky! ocianoate<br>
PEG-100stearate<br>
Glyceryl hydroxystearate<br>
Stearyl alcohol<br>
Stearic acid<br>
TEA, 99%<br>
Dimethicone<br>
Sorbitan monostearate<br>
Magnesium aluminum silicate<br>
Vitamin E acetate<br>
Cholesterol<br>
Simethicone<br>
Xanthan gum<br>
Hydroxyethylcellulose<br>
Propylparaben<br>
Disodium EDTA<br>
Butylated hydroxytolene<br>
7-hydroxy-3-phenylcoumarin<br>
Niacinamide<br>
Metal oxide<br>
Methylparaben<br>
Water<br>
Tola!<br>
*BAL means Balance. 10<br>
EXAMPLE 2<br>
Additional cosmetic compositions within the scope of the invention were prepared.<br><br>
WO 2007/112853	-	PCTYEP2007/002440<br>
TABLE 3<br><br>
	Wt%	Phase<br>
Water, Dl	BALANCE	A<br>
Disodium EDTA	0.05	A<br>
Magnesium aluminum silicate	0.6	A<br>
Methyl paraben	0.15	A<br>
Simethicone	0.01	A<br>
Butylene glycol 1,3	3.0	A<br>
Hydroxyethylcellulose	0.5	A<br>
Glycerine, USP	2.0	A<br>
Xanthan gum	0.2	A<br>
Triethanolamine	1.2	B<br>
Stearic acid	3.0	B<br>
Propyl paraben NF	0.1	B<br>
Glyceryl hydroxystearate	1.5	B<br>
Stearyl alcohol	1.5	B<br>
isostearyl palmitate	6.0	B<br>
C12-15 alcohols octanoate	3.0	B<br>
Dimethicone	1.0	B<br>
Cholesterol NF	0.5	B<br>
Sorbitan stearate	1.0	B<br>
Micronized titanium dioxide	5.0	C<br>
Tocopheryl acetate	0.1	B<br>
PEG-100 stearate	2.0	B<br>
Sodium stearoyl lactylate	0.5	B<br>
Hydroxycaprylic acid	0.1	C<br>
7-Hydroxy-3-phenylcoumarin	10.0	C<br>
Parsol MCX	2.4	C<br>
Alpha-bisabolol	0.2                [C<br>
The composition of this example was prepared as follows: 5      1.      Heat phase A to 80°C<br><br>
_     WO_2007/J12853 _	PCT/EP200 7/002440<br>
- 13-<br>
2.	Heat phase B to 75°C in a separate container<br>
3.	Add phase B to phase A and mix with heat off for 30 min.<br>
4.	At 50°C add phase C and mix for 10 min.<br>
5      EXAMPLES 3-10<br>
A set of additional compositions useful in the methods of the present invention were prepared within the scope of the present invention and are listed in the table below.<br>
TABLE 4<br><br>
Ingredients	Phase	Examples (weight %)<br>
		3<br>
acid soap base	4	5	6	7	8	9	10<br>
Stearic acid	A	17.9	17.9	17.9	17.9	17.9	17.9	17.9	17.9<br>
Sodium cetearyl sulfate (emuisifier)	A		2.2		1	1.5	2	3	2<br>
Myrj 59 (emuisifier)	A			2	2	2	2	2	1<br>
Span 60 (emulsifiers)	A			2	2	2	2	2	1<br>
7-hydroxy-3-phenylcoumarin	B	0.05	0.05	2.0	2.0	3.5	3.5	5.0	10.0<br>
Micronized zinc oxide	B	2.50	5.00	5.00	2.50	2.50	5.00	2.50	5.00<br>
KOH, 22% (form in situ soap with stearic acid)		2.20							<br>
Octy) methoxycinnamate		2.50			2.50	2.50		2.50	<br>
Water	B	BAL	BAL	BAL	BAL	BAL	BAL	BAL	BAL<br>
Glycerin	B	1	1	1 .	1	1	1	1	1<br>
EXAMPLE 11<br>
This example shows the skin lightening effect of using 7-hydroxy-3-phenylcoumarin as skin lightening agent in accordance with the inventive method. This experiment was carried out 15     using MatTek Corporation MeianoDerm cultures.   Luminescence was measured using a chromameter to assay the degree of melanization of a 3-D skin model.<br>
Method for MeianoDerm Cultures<br>
MeianoDerm cultures were obtained from MatTek Corporation, Ashland, Massachusetts,<br>
20     The MeianoDerm was maintained according to the manufacturer's instructions.   The<br>
basal media used for the maintenance of the MeianoDerm cultures was Dulbeccco's<br>
Modified Eagle Media (DMEM) supplemented with unspecified quantities of epidermal<br><br>
WO 2007/112853	PCT/EP2007/002440<br>
-14-<br>
growth   factor,   insulin,   hydrocortisone,   and   proprietary   epidermal   differentiation compounds, in addition to anti-fungal agents and antibiotics.<br>
For the long term maintenance of the MelanoDerms, the basal media was supplemented<br>
5     with both basic fibroblast growth factor (bFGF) and a-melanocyte-stimulating hormone (a-<br>
MSH), compounds which are stimulators of melanocyte growth and melanogenesis. The<br>
cultures were fed every other day for a total of two weeks.   Fresh active preparations,<br>
prepared in dimethyl sutphoxide (DMSO) or culture media, were also applied to the<br>
MelanoDerms when feeding was performed.    Each treatment condition was done in<br>
10     duplicate and digital photographs were taken of the MelanoDerm cultures to assess<br>
overall pigmentation. Microscopic images of the MelanoDerms were taken to assess the<br>
cell viability of the keratinocytes and melanocytes. For further evidence that the<br>
treatments were/not cytotoxic,   an  lactate dehydrogenase (LDH) assay (Promega,<br>
Madison, Wt) was performed on the supematants from 24 hour post-treatment cultures.<br>
15<br>
Solvable Melanin Assay To prepare tissues for assay:<br>
After treatment tissues are usually frozen until completion of the experiment. Thaw tissues, a few at a time and place in Dulbecco's phosphated buffer solution (D-PBS) to 20 remove excess phenol red from the culture medium and residual test article. Remove a single tissue from the insert. Blot dry and place in 1.7 ml. microfuge tube. Repeat for all samples. Add 250 ul Solvable™ (Tissue and Gel Solubil'rzer 0.5 M—Packard BioScience Co. Catalogue No. 6NE9100 (NEF910)). Close the tube and make sure that the tissue is completely submerged. Incubate at 60° C overnight along with standards. In 25 the morning, vortex the samples. Sometimes thick tissues will require additional time to complete the solution process.<br>
To prepare standard:<br>
Dissolve melanin (Sigma cat. M 6631) in Solvable™ at 1mg/ml.   The solution may be 30     warmed gently for 15 minutes at 37° C. Store solution in dark.<br>
To prepare standard curve:<br>
Prepare dilutions from the standard containing Oug to 250 ug of melanin in a total of 250 ul Solvable™. Incubate dilutions along with samples. 35<br><br>
_  WO 2007/112853		__	PCT/EP20Q 7/002440<br>
To read assay:<br>
Cool samples and standards. Centrifuge at 13,000 rpm for 5 minutes to pellet. Fill microwell plate (C-96) with 200 ul each of samples and standards. There is some foaming of samples when pipetted. Blow gentfy across the samples to break bubbles 5 prior to reading the plate. Read plate at 490nm. The results are shown in the table below.<br>
TABLE 5<br><br>
mg/ml.mefantn standard -.■ .■■,,.'■.-.*$£	;Op=490..nmi<br>
800	2.727<br>
400	1.321<br>
200	0.573<br>
100	0.321<br>
50	0.184<br>
25	0.065<br>
controls	;OD=490„hrri<br>
DMSO	1.292<br>
Untreated	1.259<br>
7-hydroxy-3^phenylcbumarih (DM) "'	OD=490:hni<br>
25	1.674<br>
50	1.339<br>
75	0.849<br>
100	0.293<br>
From the results tabulated above it appears that 7-hydroxy-3-phenyicoumarin compounds of the present invention reduce melanin synthesis.<br>
15 It should be understood that the specific forms of the invention herein illustrated and described are intended to be representative only. Changes, including but not limited to those suggested in this specification, may be made in the illustrated embodiments without departing from the clear teachings of the disclosure. Accordingly, reference should be made to the following appended claims in determining the full scope of the invention.<br><br>
WO 2007/112853                                                     ,                                            PCT/EP2007/002440<br>
                                    16	—	__.<br>
CLAIMS<br>
1.        A cosmetic method  of skin  lightening comprising  applying  to the skin a composition comprising;<br>
5	a.   0.000001 to 50 % of a compound of general formula I:<br>
(0<br><br>
wherein R1 and/or R2 may be positioned at the 1 -, 2-, 3-, 5-, and/or 6- positions<br>
10	on the phenyl ring;<br>
each or both Ri and/or R2 represents a hydrogen atom, OH, C1-C4 acyl group, or C1-C4 alkyl group; and<br>
R represents a hydrogen atom, C1-C4 acyl group, or C1-C4 alkyl group; and b.   a cosmetically acceptable carrier. 15<br>
2.        The cosmetic method of claim 1, wherein said compound has general formula II:<br>
00<br><br>
3.	The cosmetic method of claim 1, wherein R1 and R2 represent hydrogen.<br>
20<br>
4.	The cosmetic method  of claim   1, wherein said  compound  is 7-hydroxy-3-<br>
phenylcoumarin of formula III:<br>
(III)<br><br>
*	EP2007002440<br>
-17-	<br>
5.	The cosmetic method of claim 1, wherein said composition farther comprises a<br>
sunscreen.<br>
6.	The cosmetic method of claim 5, wherein said sunscreen is a micronized metal<br>
5                oxide.<br>
7.	The cosmetic method according to claim 1, wherein said composition further<br>
comprises a skin benefit agent selected from the group consisting of alpha-<br>
hydroxy acids,  beta-hydroxy acids,  polyhydroxy acids, hydroquinone,  t-butyl<br>
10	hydroquinone, vitamin C derivatives, dioic acids, retinoids, resorcinol derivatives<br>
and mixtures thereof.<br>
8.        The cosmetic method of claim 1, wherein said composition further comprises an<br>
organic sunscreen  selected from  the group consisting  of benzophenone-3,<br>
15	benzophenone-4,       behzophenone-8,       DEA       methoxycinnamaie,       ethyl<br>
dihydroxypropyl-PABA, glyceryl PABA, homosafate, methyl anthranilate,<br>
octocrylene, octyl dimethyl PABA, octyl methoxycinnamate (Parsol MCX), octy)<br>
salicylate, PABA, 2-phenytbenzimidazo!e-5-sijlphonic acid, TEA salicylate, 3-(4-<br>
methylbenzylidenej-camphor,	benzophenone-1,	benzophenone-2,<br>
20	benzophenone-6,    benzophenone-12,    4~isopropyl    dibenzoylmethane,    butyl<br>
methoxydibenzoylmethane (Parsol 1789), etocrylene and mixtures thereof.<br>
9.        A cosmetic composition comprising:<br>
a.   0.000001 to 50 % of a compound of general formula I:<br>
25	(I)<br><br>
wherein R, and/or R2may be positioned at the 1-, 2-, 3-, 5-, and/or 6- positions on the phenyl ring;<br>
each or both Ri arid/or R2 represents a hydrogen atom, OH, C1-C4 acyl group,<br>
30	or C1-C4 alkyl group;<br>
"rMncncucFT	iilisl<br><br><br>
-18-'	EP2007002440<br>
R represents a hydrogen atom, C1-C4 acyl group, or C1-C4 afkyf group;<br>
b.	an organic and/or inorganic sunscreen; and<br>
c.	a cosmetically acceptable carrier.<br>
5      10.       The cosmetic composition of claim 9, wherein said compound is a compound of general formula II:<br>
(II)<br><br>
11.       The cosmetic composition of claim 9, wherein said compound is a compound of<br>
10	. formula III:<br>
(HI)<br><br><br><br>
20<br>
12.       The cosmetic composition of claim 9, wherein R1 and R2 both represent hydrogen.<br>
25      13.       The cosmetic composition of claim 9, wherein said compound comprises 0.00001 % to 10 % of said composition.<br>
14.	The cosmetic composition of claim 9t"wherein said compound comprises 0.001 %<br>
to 7 % of said composition.<br>
30<br>
15.	The cosmetic composition of claim 9, wherein said compound comprises 0.01 %<br>
to 5 % of said composition.<br>
16.	A cosmetic composition for skin lightening, comprising:<br>
35	a.  0.000001 to 50 % of a compound of general formula I:<br><br>
AMENDED SHEET	<br><br>
K3r<br><br>
I^T1<br><br>
16th January 2008) 	EP2007002-:<br>
-19-<br>
(0<br><br><br><br><br>
.5<br>
10<br><br>
wherein Rt and/or R2 may be positioned at the 1-, 2-, 3-, 5-, and/or 6- positions<br>
on the phenyl ring;<br>
each or both R, and/or R2 represents a hydrogen atom, OH, C1-C4 acyl group,<br>
or C1-C4 alkyl group;<br>
R represents a hydrogen atom, C1-C4 acyl group, or C1-C4 alkyl group;<br>
b.	an organic and/or inorganic sunscreen; and<br>
c.	a cosmetically acceptable carrier.<br><br>
Dated this 25th day of September 2008<br><br>
AMENDED SHEET	'	S#S<br></td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1tdW1ucC0yMDA4LWFzc2lnbm1lbnQucGRm" target="_blank" style="word-wrap:break-word;">2050-mumnp-2008-assignment.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1NVU1OUC0yMDA4LUNMQUlNUyhBTUVOREVEKS0oMjMtNy0yMDEyKS5wZGY=" target="_blank" style="word-wrap:break-word;">2050-MUMNP-2008-CLAIMS(AMENDED)-(23-7-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1NVU1OUC0yMDA4LUNMQUlNUyhHUkFOVEVEKS0oNy0zLTIwMTQpLnBkZg==" target="_blank" style="word-wrap:break-word;">2050-MUMNP-2008-CLAIMS(GRANTED)-(7-3-2014).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1NVU1OUC0yMDA4LUNMQUlNUyhNQVJLRUQgQ09QWSktKDIzLTctMjAxMikucGRm" target="_blank" style="word-wrap:break-word;">2050-MUMNP-2008-CLAIMS(MARKED COPY)-(23-7-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1tdW1ucC0yMDA4LWNsYWltcy5kb2M=" target="_blank" style="word-wrap:break-word;">2050-mumnp-2008-claims.doc</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1tdW1ucC0yMDA4LWNsYWltcy5wZGY=" target="_blank" style="word-wrap:break-word;">2050-mumnp-2008-claims.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1NVU1OUC0yMDA4LUNPUlJFU1BPTkRFTkNFKDEtMTItMjAwOSkucGRm" target="_blank" style="word-wrap:break-word;">2050-MUMNP-2008-CORRESPONDENCE(1-12-2009).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1NVU1OUC0yMDA4LUNPUlJFU1BPTkRFTkNFKDEzLTEtMjAxNCkucGRm" target="_blank" style="word-wrap:break-word;">2050-MUMNP-2008-CORRESPONDENCE(13-1-2014).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1NVU1OUC0yMDA4LUNPUlJFU1BPTkRFTkNFKDIwLTktMjAxMCkucGRm" target="_blank" style="word-wrap:break-word;">2050-MUMNP-2008-CORRESPONDENCE(20-9-2010).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1NVU1OUC0yMDA4LUNPUlJFU1BPTkRFTkNFKDI0LTEtMjAxMykucGRm" target="_blank" style="word-wrap:break-word;">2050-MUMNP-2008-CORRESPONDENCE(24-1-2013).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1NVU1OUC0yMDA4LUNPUlJFU1BPTkRFTkNFKDI5LTEyLTIwMDkpLnBkZg==" target="_blank" style="word-wrap:break-word;">2050-MUMNP-2008-CORRESPONDENCE(29-12-2009).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1NVU1OUC0yMDA4LUNPUlJFU1BPTkRFTkNFKElQTyktKDctMy0yMDE0KS5wZGY=" target="_blank" style="word-wrap:break-word;">2050-MUMNP-2008-CORRESPONDENCE(IPO)-(7-3-2014).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1tdW1ucC0yMDA4LWNvcnJlc3BvbmRlbmNlLnBkZg==" target="_blank" style="word-wrap:break-word;">2050-mumnp-2008-correspondence.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1tdW1ucC0yMDA4LWRlc2NyaXB0aW9uKGNvbXBsZXRlKS5kb2M=" target="_blank" style="word-wrap:break-word;">2050-mumnp-2008-description(complete).doc</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1tdW1ucC0yMDA4LWRlc2NyaXB0aW9uKGNvbXBsZXRlKS5wZGY=" target="_blank" style="word-wrap:break-word;">2050-mumnp-2008-description(complete).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1NVU1OUC0yMDA4LURFU0NSSVBUSU9OKEdSQU5URUQpLSg3LTMtMjAxNCkucGRm" target="_blank" style="word-wrap:break-word;">2050-MUMNP-2008-DESCRIPTION(GRANTED)-(7-3-2014).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1tdW1ucC0yMDA4LWZvcm0gMS5wZGY=" target="_blank" style="word-wrap:break-word;">2050-mumnp-2008-form 1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1NVU1OUC0yMDA4LUZPUk0gMTMoNy0yLTIwMTIpLnBkZg==" target="_blank" style="word-wrap:break-word;">2050-MUMNP-2008-FORM 13(7-2-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1NVU1OUC0yMDA4LUZPUk0gMTgoMjktMTItMjAwOSkucGRm" target="_blank" style="word-wrap:break-word;">2050-MUMNP-2008-FORM 18(29-12-2009).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1NVU1OUC0yMDA4LUZPUk0gMihHUkFOVEVEKS0oNy0zLTIwMTQpLnBkZg==" target="_blank" style="word-wrap:break-word;">2050-MUMNP-2008-FORM 2(GRANTED)-(7-3-2014).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1NVU1OUC0yMDA4LUZPUk0gMihUSVRMRSBQQUdFKS0oR1JBTlRFRCktKDctMy0yMDE0KS5wZGY=" target="_blank" style="word-wrap:break-word;">2050-MUMNP-2008-FORM 2(TITLE PAGE)-(GRANTED)-(7-3-2014).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1tdW1ucC0yMDA4LWZvcm0gMih0aXRsZSBwYWdlKS5wZGY=" target="_blank" style="word-wrap:break-word;">2050-mumnp-2008-form 2(title page).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1tdW1ucC0yMDA4LWZvcm0gMi5kb2M=" target="_blank" style="word-wrap:break-word;">2050-mumnp-2008-form 2.doc</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1tdW1ucC0yMDA4LWZvcm0gMi5wZGY=" target="_blank" style="word-wrap:break-word;">2050-mumnp-2008-form 2.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1NVU1OUC0yMDA4LUZPUk0gMygxMC0xMi0yMDEzKS5wZGY=" target="_blank" style="word-wrap:break-word;">2050-MUMNP-2008-FORM 3(10-12-2013).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1NVU1OUC0yMDA4LUZPUk0gMygxMi04LTIwMTEpLnBkZg==" target="_blank" style="word-wrap:break-word;">2050-MUMNP-2008-FORM 3(12-8-2011).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1NVU1OUC0yMDA4LUZPUk0gMygxNS0yLTIwMTEpLnBkZg==" target="_blank" style="word-wrap:break-word;">2050-MUMNP-2008-FORM 3(15-2-2011).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1NVU1OUC0yMDA4LUZPUk0gMygxNS0yLTIwMTIpLnBkZg==" target="_blank" style="word-wrap:break-word;">2050-MUMNP-2008-FORM 3(15-2-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1NVU1OUC0yMDA4LUZPUk0gMygyMi02LTIwMTMpLnBkZg==" target="_blank" style="word-wrap:break-word;">2050-MUMNP-2008-FORM 3(22-6-2013).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1NVU1OUC0yMDA4LUZPUk0gMygyMy0xLTIwMTMpLnBkZg==" target="_blank" style="word-wrap:break-word;">2050-MUMNP-2008-FORM 3(23-1-2013).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1NVU1OUC0yMDA4LUZPUk0gMygyNC0yLTIwMTApLnBkZg==" target="_blank" style="word-wrap:break-word;">2050-MUMNP-2008-FORM 3(24-2-2010).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1NVU1OUC0yMDA4LUZPUk0gMyg0LTgtMjAxMCkucGRm" target="_blank" style="word-wrap:break-word;">2050-MUMNP-2008-FORM 3(4-8-2010).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1NVU1OUC0yMDA4LUZPUk0gMyg4LTgtMjAxMikucGRm" target="_blank" style="word-wrap:break-word;">2050-MUMNP-2008-FORM 3(8-8-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1tdW1ucC0yMDA4LWZvcm0gMy5wZGY=" target="_blank" style="word-wrap:break-word;">2050-mumnp-2008-form 3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1tdW1ucC0yMDA4LWZvcm0gNS5wZGY=" target="_blank" style="word-wrap:break-word;">2050-mumnp-2008-form 5.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1NVU1OUC0yMDA4LUdFTkVSQUwgUE9XRVIgT0YgQVRUT1JORVkoMjMtNy0yMDEyKS5wZGY=" target="_blank" style="word-wrap:break-word;">2050-MUMNP-2008-GENERAL POWER OF ATTORNEY(23-7-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1tdW1ucC0yMDA4LW90aGVyLnBkZg==" target="_blank" style="word-wrap:break-word;">2050-mumnp-2008-other.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1tdW1ucC0yMDA4LXBjdC1pYi0zMTEucGRm" target="_blank" style="word-wrap:break-word;">2050-mumnp-2008-pct-ib-311.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1tdW1ucC0yMDA4LXBjdC1pcGVhLTQwOS5wZGY=" target="_blank" style="word-wrap:break-word;">2050-mumnp-2008-pct-ipea-409.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1tdW1ucC0yMDA4LXBjdC1pcGVhLTQxNi5wZGY=" target="_blank" style="word-wrap:break-word;">2050-mumnp-2008-pct-ipea-416.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1tdW1ucC0yMDA4LXBjdC1pc2EtMjEwLnBkZg==" target="_blank" style="word-wrap:break-word;">2050-mumnp-2008-pct-isa-210.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1NVU1OUC0yMDA4LVJFUExZIFRPIEVYQU1JTkFUSU9OIFJFUE9SVCgyMy03LTIwMTIpLnBkZg==" target="_blank" style="word-wrap:break-word;">2050-MUMNP-2008-REPLY TO EXAMINATION REPORT(23-7-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1NVU1OUC0yMDA4LVVTIERPQ1VNRU5UKDIzLTctMjAxMikucGRm" target="_blank" style="word-wrap:break-word;">2050-MUMNP-2008-US DOCUMENT(23-7-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjA1MC1tdW1ucC0yMDA4LXdvIGludGVybmF0aW9uYWwgcHVibGljYXRpb24gcmVwb3J0IGExLnBkZg==" target="_blank" style="word-wrap:break-word;">2050-mumnp-2008-wo international publication report a1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=YWJzdHJhY3QxLmpwZw==" target="_blank" style="word-wrap:break-word;">abstract1.jpg</a></p>
		<br>
		<div class="pull-left">
			<a href="259305-lossless-encoding-of-information-with-guaranteed-maximum-bitrate.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="259307-apparatus-for-processing-mac-protocol-data-unit-in-communication-system.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>259306</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>2050/MUMNP/2008</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>11/2014</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>14-Mar-2014</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>07-Mar-2014</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>25-Sep-2008</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>HINDUSTAN UNILEVER LIMITED</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>HINDUSTAN UNILEVER LIMITED, UNILEVER HOUSE, B.D. SAWANT MARG, CHAKALA, ANDHERI EAST, MUMBAI -400 099</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>SHORE LEONARD J</td>
											<td>UNILEVER HOME &amp; PERSONAL CARE USA, 40 MERRITT BOULEVARD,TRUMBULL, CONNECTICUT 06611</td>
										</tr>
										<tr>
											<td>2</td>
											<td>ROCHA SHEILA ALVES</td>
											<td>UNILVER HOME &amp; PERSONAL CARE USA, 40 MERRITT BOULEVARD,TRUMBULL, CONNECTICUT 06611</td>
										</tr>
										<tr>
											<td>3</td>
											<td>MCKINNEY MARTIN D</td>
											<td>UNILVER HOME &amp; PERSONAL CARE USA, 40 MERRITT BOULEVARD,TRUMBULL, CONNECTICUT 06611</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>A61K8/49</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>PCT/EP2007/002440</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td>2007-03-19</td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td>11/393538</td>
									<td>2006-03-30</td>
								    <td>U.S.A.</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/259306-skin-lightening-agents-compositions-and-methods by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 02:29:56 GMT -->
</html>
